Recent Quotes

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, with the aim of blocking key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-05
REV		(EXPECTED)2021-08-05

Q1 2021		Est.		Actual		Surprise
EPS		-0.270		-0.360		-0.0900
REV		8.890M		19.059M		10.169M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
BCRX	BioCryst Pharmaceuticals	16.27	-0.01	-0.06%		2.9B

BioCryst Pharmaceuticals Frequently Asked Questions

How do I buy BioCryst Pharmaceuticals (BCRX) stock?

You can purchase shares of BioCryst Pharmaceuticals (NASDAQ: BCRX) through any online brokerage.

View our list of the best stock brokerages.

Who are BioCryst Pharmaceuticals's (BCRX) competitors?

Other companies in BioCryst Pharmaceuticals’s space includes: Burning Rock Biotech (NASDAQ:BNR), Karuna Therapeutics (NASDAQ:KRTX), OPKO Health (NASDAQ:OPK), Alkermes (NASDAQ:ALKS) and PTC Therapeutics (NASDAQ:PTCT).

What is the target price for BioCryst Pharmaceuticals (BCRX) stock?

The latest price target for BioCryst Pharmaceuticals (NASDAQ: BCRX) was reported by HC Wainwright & Co. on March 24, 2021. The analyst firm set a price target for 19.00 expecting BCRX to rise to within 12 months (a possible 16.71% upside). 5 analyst firms have reported ratings in the last year.

Current Stock Price for BioCryst Pharmaceuticals (BCRX)?

The stock price for BioCryst Pharmaceuticals (NASDAQ: BCRX) is $16.28 last updated Today at 8:00:02 PM.

Does BioCryst Pharmaceuticals (BCRX) pay a dividend?

There are no upcoming dividends for BioCryst Pharmaceuticals.

When is BioCryst Pharmaceuticals (NASDAQ:BCRX) reporting earnings?

BioCryst Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 5, 2021.

Is BioCryst Pharmaceuticals (BCRX) going to split?

There is no upcoming split for BioCryst Pharmaceuticals.

What sector and industry does BioCryst Pharmaceuticals (BCRX) operate in?

BioCryst Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.